EP Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$434K	Buy	7,899 +1,269	+19%	+$69.8K	﹤0.01%	839
2025 Q1	$469K	Sell	6,630 -513	-7%	-$36.3K	﹤0.01%	734
2024 Q4	$470K	Buy	7,143 +24	+0.3%	+$1.58K	﹤0.01%	712
2024 Q3	$500K	Buy	+7,119	New	+$500K	﹤0.01%	693